← Back to Search

Learning Communities for PTSD

N/A
Waitlist Available
Led By Norman Shields, PhD
Research Sponsored by Ryerson University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients must have a diagnosis of PTSD
Patients must be 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up participants will be followed for an expected duration of 12 weeks of therapy. pcl-5 will be measured at baseline, at weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, post-treatment week, and at 3-month follow-up.
Awards & highlights

Study Summary

This trial will compare the effectiveness of two different approaches to delivering evidence-based care for PTSD in three different mental health systems.

Who is the study for?
This trial is for adults with PTSD who are clients of therapists willing to use Cognitive Processing Therapy (CPT). Therapists must agree to treat 6 patients over 2 years, be open to random assignment in the study, record sessions, and have internet access. Excluded are those with uncontrolled psychotic/bipolar disorders, substance dependence, immediate suicide/homicide risk, or significant cognitive impairment.Check my eligibility
What is being tested?
The study compares two strategies aimed at sustaining and improving the delivery of CPT for PTSD within three mental health systems. It evaluates if these approaches affect patient outcomes and clinician skills differently across varying environments.See study design
What are the potential side effects?
Since this trial involves psychotherapy rather than medication, traditional 'side effects' aren't applicable. However, participants may experience emotional discomfort or distress as a natural part of therapy addressing traumatic experiences.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with PTSD.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~participants will be followed for an expected duration of 12 weeks of therapy. pcl-5 will be measured at baseline, at weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, post-treatment week, and at 3-month follow-up.
This trial's timeline: 3 weeks for screening, Varies for treatment, and participants will be followed for an expected duration of 12 weeks of therapy. pcl-5 will be measured at baseline, at weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, post-treatment week, and at 3-month follow-up. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in PTSD Symptoms over 6 months (PCL-5 measure)
Secondary outcome measures
CPT Activity Reporting
Content-Level and Context-Level Adaptation
Fidelity Measure

Trial Design

2Treatment groups
Experimental Treatment
Group I: Quality Improvement Learning CommunityExperimental Treatment1 Intervention
The Quality Improvement Learning Community arm will include clinicians who set goals related to CPT delivery, execute a plan, study results, refine plan, and continue each cycle until goals are met.
Group II: Fidelity-oriented Learning CommunityExperimental Treatment1 Intervention
The Fidelity-oriented Learning Community arm will receive fidelity consultation (adherence and competence) feedback by a CPT expert via online meetings.

Find a Location

Who is running the clinical trial?

National Center for PTSDFED
12 Previous Clinical Trials
981 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,774 Previous Clinical Trials
2,674,213 Total Patients Enrolled
Palo Alto Veterans Institute for ResearchOTHER
52 Previous Clinical Trials
7,815 Total Patients Enrolled

Media Library

Fidelity-oriented Learning Community Clinical Trial Eligibility Overview. Trial Name: NCT02449421 — N/A
Post-Traumatic Stress Disorder Research Study Groups: Quality Improvement Learning Community, Fidelity-oriented Learning Community
Post-Traumatic Stress Disorder Clinical Trial 2023: Fidelity-oriented Learning Community Highlights & Side Effects. Trial Name: NCT02449421 — N/A
Fidelity-oriented Learning Community 2023 Treatment Timeline for Medical Study. Trial Name: NCT02449421 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~9 spots leftby Mar 2025